Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - C 2011 NIA 1K01AG034999-01A1 Aging with Chronic Viral Infections and the Impact on Innate Immune Responses STOUT-DELGADO, HEATHER LOVELACE BIOMEDICAL & ENVIRONMENTAL RES NM $137,430
Hepatitis - C 2011 NIAID 5R01AI072613-05 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $406,225
Hepatitis - C 2011 NIMH 5R01MH079752-05 Role of evolving white matter damage in neurocognitive effects of HIV and HCV JERNIGAN, TERRY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $344,149
Hepatitis - C 2011 NIAID 5R01AI075099-04 Role of HCV p7 and NS2 in infectious virus production RICE, CHARLES ROCKEFELLER UNIVERSITY NY $414,092
Hepatitis - C 2011 NCI 5R01CA126807-04 HCV genetic variation and hepatocellular carcinoma TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $266,288
Hepatitis - C 2011 NIGMS 5SC2AI083926-03 Synthesis of Carbocyclic Formycin Analogues as Antiviral Agents SERBESSA, TESFAYE ELIZABETH CITY STATE UNIVERSITY NC $127,071
Hepatitis - C 2011 NIAID 5R01AI071084-03 Probing the antibody response to HCV to facilitate rational immunogen design BURTON, DENNIS SCRIPPS RESEARCH INSTITUTE CA $618,839
Hepatitis - C 2011 NIDDK 5R01DK077704-04 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $321,779
Hepatitis - C 2011 NIAID 5R37AI047367-12 HCV-specific T cell response WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $665,354
Hepatitis - C 2011 NIEHS 5K01ES017105-02 Ubiquitous pollutant acrolein inhibits IFN?? antiviral signaling: relevance to HC JOSHI-BARVE, SWATI UNIVERSITY OF LOUISVILLE KY $131,085
Hepatitis - C 2011 NIAID 5R01AI073335-04 RNA-dependent RNA Synthesis by the Hepatitis C Virus KAO, CHENG INDIANA UNIVERSITY BLOOMINGTON IN $315,195
Hepatitis - C 2011 NIAID 5R37AI047365-12 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $435,304
Hepatitis - C 2011 NCRR 5K26RR023976-03 Mouse Immunopathology LIU, CHEN UNIVERSITY OF FLORIDA FL $161,563
Hepatitis - C 2011 NIAID 5R01AI087746-02 Cyclophilins, Cyclophilin Inhibitors and Hepatitis C GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $470,003
Hepatitis - C 2011 NIAID 5R01AI087917-02 HCV NS4B: Translating molecular virology into novel antiviral therapies GLENN, JEFFREY STANFORD UNIVERSITY CA $416,837
Hepatitis - C 2011 NIDA 5R01DA012568-13 Incidence of HIV Infection in a Cohort of IV Drug Users MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,036,759
Hepatitis - C 2011 NCI 5R01CA120719-03 Markers for HCV-related HCC: plasma profiling, targeted strategies and validation BERETTA, LAURA FRED HUTCHINSON CANCER RESEARCH CENTER WA $354,244
Hepatitis - C 2011 NIAID 5R01AI088001-03 Antiviral potential of helicase inhibitors FRICK, DAVID UNIVERSITY OF WISCONSIN MILWAUKEE WI $365,558
Hepatitis - C 2011 NIAID 5K08AI077713-04 HCV diversity and resistance analyzed by DNA bar coding and pyrosequencing WANG, GARY UNIVERSITY OF FLORIDA FL $131,652
Hepatitis - C 2011 NIAID 5R01AI087925-02 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $409,613
Hepatitis - C 2011 NIAID 5R01AI069142-05 Immune Mechanisms of HCV Persistence and Pathogenesis SUN, JIAREN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $326,663
Hepatitis - C 2011 NIAID 1R01AI091953-01 Viral and Cellular Determinants of HCV Assembly LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $371,250
Hepatitis - C 2011 NCI 5R01CA057973-18 Structure and function of the HCV RNA replicase RICE, CHARLES ROCKEFELLER UNIVERSITY NY $376,233
Hepatitis - C 2011 NIAID 1R21AI092074-01 Transgenic mouse models of HCV infection and replication LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $185,625
Hepatitis - C 2011 NIAID 5R01AI060389-10 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $375,141
Hepatitis - C 2011 NIAID 5R01AI072012-05 New Antiviral Therapies for Hepatitis C Infection HERMANN, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $353,867
Hepatitis - C 2011 NIAID 5R01AI076558-03 Orally Active Nucleoside Phosphonates for Hepatitis C Virus SCHOOLEY, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $587,665
Hepatitis - C 2011 NIDDK 5R01DK080711-04 Hepatitis C Virus Quasispecies in the Resistance to Antiviral Therapy FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $288,149
Hepatitis - C 2011 NIDA 5R01DA016147-08 HBV Prevention for Homeless at Risk for HBV/HCV/HIV NYAMATHI, ADELINE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $618,727
Hepatitis - C 2011 NIAID 5R01AI069285-06 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $249,022
Hepatitis - C 2011 NINR 5R21NR011132-02 Feasibility of a HCV Decision-Making Intervention among HIV-Infected Adults BOVA, CAROL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $244,283
Hepatitis - C 2011 NIAID 5K08AI075031-04 The Pathogenesis of Autoimmunity in Hepatitis C Virus Infection CHARLES, EDGAR ROCKEFELLER UNIVERSITY NY $140,400
Hepatitis - C 2011 NIDA 5R01DA024553-03 Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site O'BRIEN, CHARLES UNIVERSITY OF PENNSYLVANIA PA $587,187
Hepatitis - C 2011 NIAID 2R01AI069000-06 Roles for microRNA-122 in hepatitis C virus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $390,924
Hepatitis - C 2011 NIDDK 1R01DK090794-01A1 Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral Infection FRENCH, SAMUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Hepatitis - C 2011 NIAID 5R21AI088351-02 HIV status and reproductive aging affect liver fibrosis in HIV/HCV infected women PETERS, MARION UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $204,372
Hepatitis - C 2011 NIAID 1R21AI088516-01A1 Natural Phenotypic Diversity of HCV NS3/4A Protease GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $222,956
Hepatitis - C 2011 NIDDK 5R01DK074673-04 Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos KHALILI, MANDANA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $434,878
Hepatitis - C 2011 NIDDK 5R01DK083356-02 Defining the intrahepatic immune response to hepatitis C virus GRAKOUI, ARASH EMORY UNIVERSITY GA $359,206
Hepatitis - C 2011 NIDA 5R44DA023722-03 Using CAI to Enhance Drug Tx Staff HCV Knowledge and Communication Skills LIBERTY, HILARY SOCIAL SCIENCES INNOVATIONS CORPORATION NY $468,485
Hepatitis - C 2011 NIDDK 5R01DK063222-08 Role of NK in Regulation of anti-viral T cell immunity HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $252,425
Hepatitis - C 2011 NIDA 5R01DA029512-02 Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $679,384
Hepatitis - C 2011 NIAID 5K01AI070001-05 Risk factors and prediction of liver disease in HIV/HCV LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $133,029
Hepatitis - C 2011 NCI 5R01CA127481-04 Hepatocarcinogenesis Secondary to Hepatitis C DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $272,731
Hepatitis - C 2011 NIAID 2R44AI074256-02 Chemical Stabilization of shRNAs and their development as hepatitis C drugs JOHNSTON, BRIAN SOMAGENICS, INC. CA $1,000,000
Hepatitis - C 2011 NIMH 5F31MH087226-02 Emotion and Relationships Underlying HIV/HCV Risk Among Incarcerated Women YARD, SAMANTHA UNIVERSITY OF WASHINGTON WA $41,800
Hepatitis - C 2011 NIAAA 2R44AA016712-03A2 Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection COWAN, ADA METALLOPHARM, LLC OH $844,040
Hepatitis - C 2011 NINDS 5F31NS070706-02 Diffusion Tensor Imaging and Neuropsychological Outcomes in HIV/HCV Co-infection HEAPS, JODI UNIVERSITY OF MISSOURI-ST. LOUIS MO $30,000
Hepatitis - C 2011 NIAID 5R01AI080703-02 Hepatitis C Virus Trafficking in Infected Hepatocytes RANDALL, GLENN UNIVERSITY OF CHICAGO IL $342,700
Hepatitis - C 2011 NIAID 5R37AI028731-22 Noncarbohydrate Approaches to AntiAIDS Nucleosides LIOTTA, DENNIS EMORY UNIVERSITY GA $347,696
Hepatitis - C 2011 NIAID 5R01AI085051-02 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $407,138
Hepatitis - C 2011 NIDDK 5F30DK088385-02 The Molecular Mechanism of Antibody Neutralization of Hepatitis C Virus SABO, MICHELLE WASHINGTON UNIVERSITY MO $46,800
Hepatitis - C 2011 NIAID 5R21AI084090-02 The role of hepatitis C virus 5' untranslated region in virus morphogenesis DASGUPTA, ASIM UNIVERSITY OF CALIFORNIA LOS ANGELES CA $185,069
Hepatitis - C 2011 NIDA 5K01DA024654-04 Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients PILLAI, SATISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $180,360
Hepatitis - C 2011 NIDDK 5K24DK066144-07 Mentoring Junior Faculty: Viral hepatitis Clinical Research FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $162,645
Hepatitis - C 2011 NIDA 5R01DA016017-09 Acute Hepatitis C Infection in Young Injectors PAGE, KIMBERLY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $992,772
Hepatitis - C 2011 NIDDK 5R01DK084139-02 Hepatitis C: E2 Molecular Mechanisms BUCK, MARTINA VETERANS MEDICAL RESEARCH FDN/SAN DIEGO CA $330,474
Hepatitis - C 2011 NCI 5R01CA123544-05 Biomarker for Hepatocellular Carcinoma WANDS, JACK RHODE ISLAND HOSPITAL RI $231,313
Hepatitis - C 2011 NIAID 5K08AI069989-05 An in vitro system to study antiviral strategies against Hepatitis C virus WYLES, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $116,370
Hepatitis - C 2011 NIAID 5R01AI079043-02 Innate Control of Hepatitis C Virus Infection: Antiviral and Evasion Mechanisms CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $470,003
Hepatitis - C 2011 NIDA 5R01DA022914-04 Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $650,621
Hepatitis - C 2011 NIDA 2R25DA013582-11 Clinical Addiction Research and Education Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $377,136
Hepatitis - C 2011 NIAID 5R03AI085226-02 Development of real time fluorescence-based assays for elucidating HCV entry dyna UPRICHARD, SUSAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $77,715
Hepatitis - C 2011 NIDA 5R01DA021550-04 HCV Transmission among Young IDUs in NYC EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $829,591
Hepatitis - C 2011 NIDDK 5K08DK088951-02 Examination of the Relationship of Host Cholesterol Biosynthesis to Chronic HCV I PENG, LEE MASSACHUSETTS GENERAL HOSPITAL MA $158,949
Hepatitis - C 2011 NIDA 5K23DA023467-04 Chronic Pain and Substance Use in Patients with Hepatitis C MORASCO, BENJAMIN OREGON HEALTH AND SCIENCE UNIVERSITY OR $166,684
Hepatitis - C 2011 NIDDK 5R21DK083560-02 FUSE Binding Protein As a Cellular Effector of HCV Replication PANDEY, VIRENDRA UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $231,660
Hepatitis - C 2011 NIAID 5R01AI052065-08 HCV and HIV Progression in Women on HAART KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $576,980
Hepatitis - C 2011 NIDA 5R01DA009832-15 Intervention to Reduce Injection Drug Use BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $492,670
Hepatitis - C 2011 NIDA 5R01DA015999-07 Treatment of recently acquired hepatitis C virus infection DORE, GREGORY UNIVERSITY OF NEW SOUTH WALES AUSTRA $355,137
Hepatitis - C 2011 NIDA 5K23DA027367-02 HCV and Pain in Substance Users With and Without HIV TSUI, JUDITH BOSTON MEDICAL CENTER MA $171,369
Hepatitis - C 2011 NIDA 5R01DA024563-05 Innate Immune Defense Against HCV and HIV: The Chimeric Mouse Model GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $381,235
Hepatitis - C 2011 NIAID 5K01AI073193-05 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs LINAS, BENJAMIN MASSACHUSETTS GENERAL HOSPITAL MA $136,375
Hepatitis - C 2011 NIAID 5R01AI090055-02 Simianizing hepatitis C: Defining the species-tropism of a hepatotropic virus RICE, CHARLES ROCKEFELLER UNIVERSITY NY $426,849
Hepatitis - C 2011 NIAID 5K08AI083785-02 Characterization of a host hepatocyte factor that regulates HCV replication TAI, ANDREW UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $132,300
Hepatitis - C 2011 NIDA 5R01DA016065-09 HCV Disease Management in HIV- HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $417,799
Hepatitis - C 2011 NIGMS 5R01GM085117-04 The Role of Arginine Methyltransferases in Interferon Signaling MOWEN, KERRI SCRIPPS RESEARCH INSTITUTE CA $371,458
Hepatitis - C 2011 NIDA 5R01DA023857-04 At Risk Hispanic Gangs: Long-Term Consequences for Hiv, Hepatitis and STI VALDEZ, AVELARDO UNIVERSITY OF HOUSTON TX $551,285
Hepatitis - C 2011 NIDA 5K23DA022454-04 Directly Observed Hepatitis C Treatment in Methadone Clinics LITWIN, ALAIN ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $182,557
Hepatitis - C 2011 NIAID 5R01AI083113-02 HCV resolution correlates with patterned KIR expressions on lymphocytes. RYAN, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $405,307
Hepatitis - C 2011 NCI 5R21CA153147-02 Role of Autotaxin in HCV-associated Hepatocellular Carcinoma KAUSHIK-BASU, NEERJA UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $197,473
Hepatitis - C 2011 NIAID 5R01AI089826-02 Structure and function of the HCV replication complex PYLE, ANNA YALE UNIVERSITY CT $591,890
Hepatitis - C 2011 NIAID 5K24AI078884-04 Complications of Chronic Viral Infections GLESBY, MARSHALL WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $182,478
Hepatitis - C 2011 NIDDK 5K01DK082613-03 Host-pathogen interactions in hepatitis C virus replication BRADRICK, SHELTON DUKE UNIVERSITY NC $110,664
Hepatitis - C 2011 NIDDK 5K23DK082621-03 Concentration-Controlled Ribavirin for the Treatment of Patients with Chronic HVC KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $167,837
Hepatitis - C 2011 NIAID 5R01AI087176-02 Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $540,263
Hepatitis - C 2011 NIDA 5R01DA016078-10 The Progression of Hepatitis C Among IDUs THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $723,353
Hepatitis - C 2011 NIDA 5R01DA022177-06 Opioids, HIV/HCV and Host Cell Innate Immunity HO, WENZHE TEMPLE UNIVERSITY PA $287,975
Hepatitis - C 2011 NCI 5R01CA122499-05 Oxidative Stress and Hepatocellular Carcinoma HUANG, TING-TING PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $258,020
Hepatitis - C 2011 RMAP 1R21NS073933-01 Development of a HTS assay to screen for inhibitors of HCV core NS3h interactions STROSBERG, ARTHUR SCRIPPS RESEARCH INSTITUTE CA $198,000
Hepatitis - C 2011 NHLBI 5R44HL071373-05 DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval LEE, HELEN DIAGNOSTICS FOR THE REAL WORLD, LTD CA $836,222
Hepatitis - C 2011 NIMH 5R01MH083553-04 Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy HINKIN, CHARLES BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE CA $594,457
Hepatitis - C 2011 NIAID 5R01AI076259-03 Molecular determinants of hepatitis C virus infectivity LINDENBACH, BRETT YALE UNIVERSITY CT $405,516
Hepatitis - C 2011 NCI 5R21CA143748-02 Regulation of hepatic NKT cells by CDld+ liver cells EXLEY, MARK BETH ISRAEL DEACONESS MEDICAL CENTER MA $183,549
Hepatitis - C 2011 NIAID 5R01AI085087-02 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $382,388
Hepatitis - C 2011 NCI 5R01CA138635-02 Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer BUTTERFIELD, LISA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $291,196
Hepatitis - C 2011 NIDDK 5R01DK081817-03 Innate Immunity and Hepatitis C Virus Infection RAY, RATNA SAINT LOUIS UNIVERSITY MO $314,429
Hepatitis - C 2011 NIDDK 5R01DK080812-03 Mechanisms of Liver Disease Progression by Hepatitis C Virus RAY, RANJIT SAINT LOUIS UNIVERSITY MO $314,429
Hepatitis - C 2011 NIDDK 5R01DK088787-02 Tight Junction: Gate to HCV Tropism, Therapeutics and Pathogenesis WANG, TIANYI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $313,281
Hepatitis - C 2011 NIDA 5R01DA025932-04 Drug Interactions in Substance Abusers with HIV Infection FRIEDLAND, GERALD YALE UNIVERSITY CT $357,593
Hepatitis - C 2011 NIGMS 5R01GM081346-04 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $187,027
Hepatitis - C 2011 NIDA 5K23DA020383-04 Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users TAYLOR, LYNN MIRIAM HOSPITAL RI $176,814
Hepatitis - C 2011 NIAID 5R01AI073963-04 Host Genetic Contribution to HCV Outcomes BLANTON, RONALD CASE WESTERN RESERVE UNIVERSITY OH $519,913
Hepatitis - C 2011 NIGMS 5R01GM066978-08 Structure, dynamics, and function of the viroporins Vpu from HIV and p7 from HCV OPELLA, STANLEY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $296,802
Hepatitis - C 2011 NIAID 5R01AI090119-02 Regulated Intramembrane Proteolysis of CREB3L1 in Innate Antiviral Response YE, JIN UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $392,288
Hepatitis - C 2011 NIMH 5R01MH090250-02 Vulnerability to major depression: The role of delta sleep in patients receiving LOTRICH, FRANCIS UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $315,596
Hepatitis - C 2011 NIAID 5F32AI091207-02 Characterization and Consequences of HCV Interaction with Host Lipoproteins SCULL, MARGARET ROCKEFELLER UNIVERSITY NY $48,398
Hepatitis - C 2011 NIAID 1R01AI089957-01A1 Novel antiviral activities of tumor necrosis factor-alpha DUSTIN, LYNN ROCKEFELLER UNIVERSITY NY $423,750
Hepatitis - C 2011 NIAID 1R01AI091707-01A1 Type I interferon-stimulated genes and the antiviral immune response RICE, CHARLES ROCKEFELLER UNIVERSITY NY $422,500
Hepatitis - C 2011 NIAID 2R01AI071068-06 RNAi for the Treatment of Viral Hepatitis KAY, MARK STANFORD UNIVERSITY CA $453,945
Hepatitis - C 2011 NIDA 5R01DA023405-05 HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $637,960
Hepatitis - C 2011 NIDDK 5R21DK091357-02 Crystal structure of signal peptide peptidase with engineered antibody fragment LIEBERMAN, RAQUEL GEORGIA INSTITUTE OF TECHNOLOGY GA $213,061
Hepatitis - C 2011 NIDA 5R01DA024565-05 Mechanisms of Hepatitis C Virus Evolution RAY, STUART JOHNS HOPKINS UNIVERSITY MD $527,079
Hepatitis - C 2011 NIAID 5R01AI080734-03 HCV Genotype 6: A Model for HCV Genetics and Molecular Epidemiology Studies LU, LING UNIVERSITY OF KANSAS MEDICAL CENTER KS $371,250
Hepatitis - C 2011 NIDDK 5K23DK077568-05 Kidney Disease in HIV-Hepatitis C Virus Co-Infection WYATT, CHRISTINA MOUNT SINAI SCHOOL OF MEDICINE NY $129,465
Hepatitis - C 2011 NIAID 5R01AI077757-03 Mechanisms of Immune Evasion by Hepatitis C Virus COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $401,841
Hepatitis - C 2011 NINDS 5K23NS051244-05 Relationship of Cytokines to Cognitive Functions in HCV HILSABECK, ROBIN UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $167,980
Hepatitis - C 2011 NIDDK 5K23DK089004-02 An Adherence and Depression Intervention for Patients During Hepatitis C Therapy EVON, DONNA UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $140,494
Hepatitis - C 2011 NCI 1R21CA152514-01A1 HCV Strain Variation and HCC BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE NY $221,198
Hepatitis - C 2011 NIGMS 2R01GM083257-03A1 Small Molecule Tools to Image Sophisticated Protein Function SCHEPARTZ, ALANNA YALE UNIVERSITY CT $288,585
Hepatitis - C 2011 NHLBI 5R01HL095136-04 Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans FREIBERG, MATTHEW UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $986,138
Hepatitis - C 2011 NIDA 5R01DA027379-03 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $498,584
Hepatitis - C 2011 NIDDK 5R01DK087877-02 Detection of Liver Fibrosis Using IVIM Diffusion and DCE MRI in HCV TAOULI, BACHIR MOUNT SINAI SCHOOL OF MEDICINE NY $337,950
Hepatitis - C 2011 NIGMS 5R01GM087738-04 Inhibition of HCV as an Opportunistic HIV Co-infection FISHBEIN, JAMES UNIVERSITY OF MARYLAND BALT CO CAMPUS MD $330,727
Hepatitis - C 2011 NIAID 5K08AI079406-04 Novel antviral targets in Hepatitis C virus NS4B protein EINAV, SHIRIT STANFORD UNIVERSITY CA $130,599
Hepatitis - C 2011 NIAID 5R01AI079150-03 Cyclosporine, Cyclophilins and HCV Replication TANG, HENGLI FLORIDA STATE UNIVERSITY FL $321,298
Hepatitis - C 2011 NIAID 5K24AI083742-03 Midcareer Investigator Award in Patient-Oriented Research (K24) ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $191,392
Hepatitis - C 2011 NIAID 1R43AI094732-01 Selection of the Optimal Nucleoside Triphosphate Mimic Prodrug Inhibitor of HCV R COOK, PHILLIP R. I. CHEMICAL, INC. CA $300,000
Hepatitis - C 2011 NIDDK 5K24DK078772-05 Patient-Oriented Research on Hepatitis in Special Populations CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $165,243
Hepatitis - C 2011 NCI 5K24CA139570-02 A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy NELSON, DAVID UNIVERSITY OF FLORIDA FL $186,940
Hepatitis - C 2011 NIDDK 5R21DK089456-02 Quantifying risk from and appropriate recipients for infectious-risk kidneys SEGEV, DORRY JOHNS HOPKINS UNIVERSITY MD $240,199
Hepatitis - C 2011 NIAID 2R42AI088793-03 Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II MURPHY, BRIAN EIGER GROUP INTERNATIONAL, INC. CA $1,000,000
Hepatitis - C 2011 NIAID 1R13DK092087-01 HCV Symposium 2011 POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $3,000
Hepatitis - C 2011 NIDDK 1R13DK092087-01 HCV Symposium 2011 POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $20,000
Hepatitis - C 2011 NIDDK 5K01DK081736-04 Genetic Epidemiology of HCV-related Liver Disease WHITE, DONNA BAYLOR COLLEGE OF MEDICINE TX $157,946
Hepatitis - C 2011 NIAID 5K08AI081544-03 HIV, Kupffer Cells, and HCV-related Liver Fibrosis BALAGOPAL, ASHWIN JOHNS HOPKINS UNIVERSITY MD $128,762
Hepatitis - C 2011 RMAP 5R01AI085583-03 Polypeptide Design with Proteomic Scope via Microfluidic mRNA Display ROBERTS, RICHARD UNIVERSITY OF SOUTHERN CALIFORNIA CA $483,504
Hepatitis - C 2011 NIAID 5R01AI073219-04 NK/DC Cross-Talk and Antiviral Response MONTANER, LUIS WISTAR INSTITUTE PA $772,006
Hepatitis - C 2011 NIDDK 5F30DK082151-03 Regulation of hepcidin and iron metabolism in liver disease GOODNOUGH, JULIA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $31,450
Hepatitis - C 2011 NIAID 5F32AI084448-03 Hepatitis C virus host interactions in micropatterened hepatocyte co-cultures SHEAHAN, TIMOTHY ROCKEFELLER UNIVERSITY NY $53,042
Hepatitis - C 2011 NCRR 5R01RR006555-20 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $466,965
Hepatitis - C 2011 NIAID 5R01AI079031-04 Discovery of potent human antibodies for prevention of (recurrent) HCV infection LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $464,322
Hepatitis - C 2011 NIGMS 5R01GM089001-03 Mechanisms of RNA binding and remodeling proteins RANEY, KEVIN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK AR $448,134
Hepatitis - C 2011 NIAAA 5R01AA018857-03 Nanog-positive cancer stem cells in and liver oncogenesis by alcohol and HCV MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $366,123
Hepatitis - C 2011 NIAAA 5R01AA008169-22 HCV in Alcoholics WANDS, JACK RHODE ISLAND HOSPITAL RI $353,744
Hepatitis - C 2011 NIAID 5R01AI075090-04 Function of NS2 in Hepatitis C Virus Assembly and Release YI, MINKYUNG UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $295,990
Hepatitis - C 2011 NCI 5K25CA127524-04 Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques SPRATT, HEIDI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $134,067
Hepatitis - C 2011 NIDA 5R01DA013324-13 Hepatitis C Pathogenesis and the Human Genome THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $703,933
Hepatitis - C 2011 NIAAA 5R37AA014372-09 HCV, Alcohol and Host Defense SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $355,764
Hepatitis - C 2011 NIDDK 4R44DK085781-02 Phase I Clinical Study Using an Antifibrotic Drug CAI, WEIZHONG ANGION BIOMEDICA CORPORATION NY $764,642
Hepatitis - C 2011 NCI 5K23CA139005-03 Optimizing localized therapy for primary liver cancer: a clinical trial and model MIKSAD, REBECCA BETH ISRAEL DEACONESS MEDICAL CENTER MA $169,199
Hepatitis - C 2011 OD 5R21DA029473-02 Crucial Transitions among Young Opioid Users in Iran MALEKINEJAD, MOHSEN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $139,878
Hepatitis - C 2011 NIDA 1R01DA031056-01A1 International Collaborative of prospective studies of HIV and Hepatitis in IDU PAGE, KIMBERLY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $483,785
Hepatitis - C 2011 NIDDK 5K08DK076565-05 Bias in Retransplantation Survival Models: Selection Criteria and Hepatitis C BIGGINS, SCOTT UNIVERSITY OF COLORADO DENVER CO $121,770
Hepatitis - C 2011 NIDA 1R01DA031074-01A1 Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs GARFEIN, RICHARD UNIVERSITY OF CALIFORNIA SAN DIEGO CA $604,516
Hepatitis - C 2011 NIDDK 5K24DK062234-08 Renal and Cardiovascular Events in Patients with Chronic Kidney Disease OJO, AKINLOLU UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $147,366
Hepatitis - C 2011 NIAID 5R01AI080659-02 Mechanistic Studies of HCV E2 MARCOTRIGIANO, JOSEPH RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $381,769
Hepatitis - C 2011 NIAID 5R01DA030747-02 CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC) BECKWITH, CURT MIRIAM HOSPITAL RI $291,000
Hepatitis - C 2011 NIDA 5R01DA030747-02 CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC) BECKWITH, CURT MIRIAM HOSPITAL RI $345,536
Hepatitis - C 2011 NIDA 5R01DA030234-02 Behavioral Science Aspects of Rapid Test Acceptance FISHER, DENNIS CALIFORNIA STATE UNIVERSITY LONG BEACH CA $511,146
Hepatitis - C 2011 NIDDK 5U01DK062498-10 Adult-to-Adult Living Donor Liver Transplantation Study Data Coordinating Center MERION, ROBERT UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $772,072
Hepatitis - C 2011 NIDDK 5U01DK062483-10 Adult to Adult Living Donor Liver Transplantation Cohort Study EMOND, JEAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $250,001
Hepatitis - C 2011 NIDDK 5U01DK062536-10 Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) EVERSON, GREGORY UNIVERSITY OF COLORADO DENVER CO $172,344
Hepatitis - C 2011 NIDDK 5U01DK062531-10 Adult to Adult Living Donor Liver Transplantation FISHER, ROBERT VIRGINIA COMMONWEALTH UNIVERSITY VA $191,198
Hepatitis - C 2011 NIDDK 5U01DK062444-10 Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients FREISE, CHRIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $316,021
Hepatitis - C 2011 NIDDK 5U01DK085563-03 University Health Network's Application to Join the A2ALL Consortium GRANT, DAVID UNIVERSITY HEALTH NETWORK CANADA $278,856
Hepatitis - C 2011 NIDA 1R01DA027195-01A2 Reducing HCV/HIV Risk Behaviors among Injection Drug Users in China DU, JIANG SHANGHAI MENTAL HEALTH CENTER CHINA $104,036
Hepatitis - C 2011 NIDA 5R01DA029880-02 HIV and Drug Use in Georgian Women JONES, HENDREE RESEARCH TRIANGLE INSTITUTE NC $462,967
Hepatitis - C 2011 NIDA 5R37DA013806-12 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $655,781
Hepatitis - C 2011 NIDDK 5R01DK090317-02 Clinical Outcomes and the HCV Core Gene BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE NY $348,195
Hepatitis - C 2011 NIDDK 5R01DK083479-02 Hepatitis C Virus-Induced Liver Pathogenesis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $317,552
Hepatitis - C 2011 RMAP 5R01GM095638-02 Engineered antibody fragments for cocrystallization with signal peptide peptidase MAYNARD, JENNIFER UNIVERSITY OF TEXAS AUSTIN TX $297,000
Hepatitis - C 2011 NIAID 1R01AI095680-01 The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate LANFORD, ROBERT TEXAS BIOMEDICAL RESEARCH INSTITUTE TX $547,534
Hepatitis - C 2011 NIAID 1R01AI095690-01 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $368,389
Hepatitis - C 2011 NIDA 1R01DA030420-01A1 Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro HEIMER, ROBERT YALE UNIVERSITY CT $453,706
Hepatitis - C 2011 NCCAM 1R01AT007297-01 Inflammation, Stress, and Social Behavior: Using Ecological Assessments and Model RAISON, CHARLES EMORY UNIVERSITY GA $546,327
Hepatitis - C 2011 NIDDK 1R01DK090014-01A1 CARD14 is essential for hepatitis C virus replication and activation of NFKB TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $495,000
Hepatitis - C 2011 NIMH 5R01MH085538-03 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $345,263
Hepatitis - C 2011 NIAID 1R01AI078881-01A2 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $353,913
Hepatitis - C 2011 NIAAA 1R01AA019976-01A1 Developmental pathways, environmental agents, and epigenetics in liver disease ROBERTSON, KEITH GEORGIA HEALTH SCIENCES UNIV RES INSTIT GA $630,122
Hepatitis - C 2011 NIAAA 3R01AA018001-03S1 Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection MCCANCE-KATZ, ELINORE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $151,549
Hepatitis - C 2011 NIAAA 1R21AA020078-01A1 Genetic Alterations Promoting Alcohol Induced Hepatic Carcinogenesis CHEN, XIN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $183,469
Hepatitis - C 2011 NIDDK 1K08DK090576-01A1 The role of innate immune evasion in hepatitis C virus infection DE JONG, YPE WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $151,902
Hepatitis - C 2011 NCCAM 1R01AT006842-01 Mechanisms of Silymarin Hepatoprotection POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $470,250
Hepatitis - C 2011 NIAID 2R44AI081335-03A1 Agonists of the RIG-I Innate Immune Pathway IADONATO, SHAWN KINETA, INC. WA $1,000,000
Hepatitis - C 2011 NIDDK 3R01DK084139-01A1S1 Hepatitis C: E2 Molecular Mechanisms BUCK, MARTINA VETERANS MEDICAL RESEARCH FDN/SAN DIEGO CA $39,592
Hepatitis - C 2011 NIDA 2R13DA022952-05A1 International Society for Addiction Medicine Annual Conference BUNT, GREGORY DAYTOP VILLAGE NY $40,000
Hepatitis - C 2011 NIAID 1K23AI096913-01 Moving Towards More Individualized Therapies in HIV/HCV Co-infected Patients NAGGIE, SUSANNA DUKE UNIVERSITY NC $88,700
Hepatitis - C 2011 NIAAA 1U01AA020790-01 Alcohol and Multisubstance Use in the Veterans Aging Cohort Study JUSTICE, AMY YALE UNIVERSITY CT $596,217
Hepatitis - C 2011 NIAAA 1U24AA020794-01 Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use JUSTICE, AMY YALE UNIVERSITY CT $777,196
Hepatitis - C 2011 NIDA 1R01DA033541-01A1 Discovery and Assessment of Genetic Determinants of HCV and HIV Control CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $725,722
Hepatitis - C 2011 NIAID 5U54AI057160-08 5901 Hepatitis C virus escape mechanisms from innate immunity RAY, RANJIT SAINT LOUIS UNIVERSITY MO $384,027
Hepatitis - C 2011 NIDA 3R01DA024553-03S1 Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site O'BRIEN, CHARLES UNIVERSITY OF PENNSYLVANIA PA $116,960
Hepatitis - C 2011 NIAID 5U19AI088791-02 7997 Cellular Immune Response to Acute HCV Infection COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $188,831
Hepatitis - C 2011 NIAID 5U19AI088791-02 7998 Humoral Immune Response to Acute HCV Infection RAY, STUART JOHNS HOPKINS UNIVERSITY MD $221,762
Hepatitis - C 2011 NIAID 5U19AI088791-02 7999 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $87,819
Hepatitis - C 2011 NIAID 5U19AI088791-02 8000 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $266,901
Hepatitis - C 2011 NCI 1R21CA158508-01A1 Virus-gene interactions during hepatic carcinogenesis CHEN, XIN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $168,019
Hepatitis - C 2011 NIAID 5U19AI088778-02 8051 Mechanisms Of Pathogen Recognition And Innate Immune Control Of Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $235,609
Hepatitis - C 2011 NIAID 5U19AI088778-02 8052 Mechanism Of Interferon Induction By The Hepatitis C Virus CHISARI, FRANCIS SCRIPPS RESEARCH INSTITUTE CA $417,992
Hepatitis - C 2011 NIAID 5U19AI088778-02 8054 Administrative Core GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $73,826
Hepatitis - C 2011 NIAID 5U19AI088778-02 8055 Clinical Core and Data Coordination Center LAU, DARYL BETH ISRAEL DEACONESS MEDICAL CENTER MA $119,690
Hepatitis - C 2011 NIDA 5P20DA026133-03 8236 Effect of HCV Infection on Proteomic Readout of Immune Activation During HIV Infe ANTHONY, DONALD CASE WESTERN RESERVE UNIVERSITY OH $134,616
Hepatitis - C 2011 NIDDK 1R01DK094652-01 Hepatitis C virus and autophagic response OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $355,439
Hepatitis - C 2011 NIDDK 1F32DK094671-01 Regulation of host cell gene expression by the hepatitis C virus protein NS5A DEBES, JOSE UNIVERSITY OF MINNESOTA TWIN CITIES MN $60,962
Hepatitis - C 2011 NIAID 5U19AI083025-03 5042 Hepatitis C virus and intracellular antiviral OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $256,779
Hepatitis - C 2011 NIDA 3R01DA023857-04S1 At Risk Hispanic Gangs: Long-Term Consequences for Hiv, Hepatitis and STI VALDEZ, AVELARDO UNIVERSITY OF HOUSTON TX $93,000
Hepatitis - C 2011 NIDA 3R01DA024553-03S2 Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site O'BRIEN, CHARLES UNIVERSITY OF PENNSYLVANIA PA $45,057
Hepatitis - C 2011 NIAID 5U19AI082630-03 8627 The Central Role of the Hepatocyte in HCV Persistence CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $304,733
Hepatitis - C 2011 NIAID 5U19AI082630-03 8628 Phenotype and Function of Liver Homing T Cells KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $333,465
Hepatitis - C 2011 NIAID 5U19AI082630-03 8629 Funtional T-cell Failure in Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $412,433
Hepatitis - C 2011 NIAID 5U19AI082630-03 8630 Impact of CTL Escape Mutations on HCV Replicative Fitness ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $347,454
Hepatitis - C 2011 NIAID 5U19AI082630-03 8631 Technology Development Project HAINING, WILLIAM DANA-FARBER CANCER INSTITUTE MA $584,742
Hepatitis - C 2011 NIAID 5U19AI082630-03 8632 Administrative Core for the HCV Persistence Study Group (HPSG) CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $231,284
Hepatitis - C 2011 NIAID 5U19AI082630-03 8633 Pilot/Feasibility Studies Program of the HCV Persistence Study Group (HPSG) CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $195,444
Hepatitis - C 2011 NIAID 5U19AI082630-03 8634 Core C-Antibody Core FREEMAN, GORDON DANA-FARBER CANCER INSTITUTE MA $317,521
Hepatitis - C 2011 NIAID 5U19AI082630-03 8635 Tissue, Cell and Plasma Repository MISDRAJI, JOSEPH MASSACHUSETTS GENERAL HOSPITAL MA $147,852
Hepatitis - C 2011 NIEHS 5P01ES006052-18 0005 RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman) GROOPMAN, JOHN JOHNS HOPKINS UNIVERSITY MD $486,174
Hepatitis - C 2011 NIAID 1R56AI087769-01A1 Nonstructural 4B protein and hepatitis C virus replication complex KONAN, KOUACOU ALBANY MEDICAL COLLEGE NY $392,758
Hepatitis - C 2011 NIAID 5U19AI088790-02 8022 Mechanisms of effective innate immunity in HCV treatment RYAN, JAMES UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $197,382
Hepatitis - C 2011 NIAID 5U19AI088790-02 8023 Mechanisms of effective adaptive immunity in HCV treatment MCCUNE, JOSEPH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $164,762
Hepatitis - C 2011 NIAID 5U19AI088790-02 8024 Clinical and Epidemiology Core TERRAULT, NORAH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $246,284
Hepatitis - C 2011 NIAID 5U19AI088790-02 8025 Administrative Core MCCUNE, JOSEPH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $100,635
Hepatitis - C 2011 NCI 5P01CA123328-05 0003 Role of Inflammation and DNA Damage-Repair in HCV Carcinogenesis LAI, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $270,612
Hepatitis - C 2011 NIAID 1R56AI091840-01 HCV-Host Interactions During Antiviral Therapy POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $250,868
Hepatitis - C 2011 NIDA 5P30DA015625-10 9001 FUNCTIONAL GENOMICS & VIROLOGY CORE KATZE, MICHAEL UNIVERSITY OF WASHINGTON WA $765,199
Hepatitis - C 2011 NIDA 5P30DA015625-10 9002 PROTEOMICS CORE CARLISS, RICHARD UNIVERSITY OF WASHINGTON WA $685,604
Hepatitis - C 2011 NIDA 5P30DA015625-10 9003 BIONFORMATICS & BIOSTATISTICS CORE EMERSON, SCOTT UNIVERSITY OF WASHINGTON WA $236,314
Hepatitis - C 2011 NIDA 5P30DA015625-10 9004 Administrative Core KATZE, MICHAEL UNIVERSITY OF WASHINGTON WA $151,837
Hepatitis - C 2011 RMAP 3R21NS066411-01A1S1 Novel Assay for Small Molecule Inhibitors of core-NS5A Interaction STROSBERG, ARTHUR SCRIPPS RESEARCH INSTITUTE CA $49,500
Hepatitis - C 2011 NIAID 5U19AI082642-03 8115 Dendritic cell-based vaccination against hepatitis C GREGORY, STEPHEN UNIVERSITY OF RHODE ISLAND RI $620,745
Hepatitis - C 2011 NIAID 5U19AI082642-03 8119 TRIAD Administrative Core DE GROOT, ANNE UNIVERSITY OF RHODE ISLAND RI $198,508
Hepatitis - C 2011 NIDDK 5P30DK034989-28 7469 Pilot and Feasibility Program BOYER, JAMES YALE UNIVERSITY CT $3
Hepatitis - C 2011 NCCAM 3U01AT003566-04S2 Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente BELLE, STEVEN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $50,368
Hepatitis - C 2011 NIDA 5P30DA013868-09 9011 Hepatitis and Liver Function Core KNOX, TAMSIN TUFTS UNIVERSITY BOSTON MA $117,913
Hepatitis - C 2011 NIAID 4U19AI089992-02 7139 Immune signatures of clinical responses to flavivirus infections FIKRIG, EROL YALE UNIVERSITY CT $482,125
Hepatitis - C 2011 NIAID 5U19AI066345-07 8005 The role of NK cells during acute HCV infection and antiviral therapy ALTER, GALIT MASSACHUSETTS GENERAL HOSPITAL MA $165,696
Hepatitis - C 2011 NIAID 5U19AI066345-07 8006 Administrative Core LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $96,396
Hepatitis - C 2011 NIAID 5U19AI066345-07 8007 Acute HCV infection in Rio de Janeiro RODRIGUES, LIA FUNDACAO OSWALDO CRUZ BRAZIL $163,321
Hepatitis - C 2011 NIAID 5U19AI066345-07 8008 Acute HCV in the prison population KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $160,747
Hepatitis - C 2011 NIGMS 3R01GM089001-02S1 Mechanisms of RNA binding and remodeling proteins RANEY, KEVIN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK AR $8,201
Hepatitis - C 2011 NINR 5P01NR010948-04 0002 Uncertainty management in patients awaiting liver transplant BAILEY, DONALD DUKE UNIVERSITY NC $89,303
Hepatitis - C 2011 NIDDK 3R01DK090317-02S1 Clinical Outcomes and the HCV Core Gene BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE NY $69,851
Hepatitis - C 2011 NIAID Y1AI2669-10-0-1 Arthritis and Autoimmunity in Chronic Hepatitis C Virus Infection NO PI IDENTIFIED NIH $54,000
Hepatitis - C 2011 NIAID 5U19AI066328-07 8030 Immune Escape Strategies in Hepatitis C ROSEN, HUGO UNIVERSITY OF COLORADO AT DENVER CO $229,959
Hepatitis - C 2011 NIAID 5U19AI066328-07 8031 Role of HCV* Hepatocyte in Regulation of Antiviral T cell Immunity HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $221,988
Hepatitis - C 2011 NIAID 5U19AI066328-07 8032 Chemokines and Acute Hepatitis C POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $224,447
Hepatitis - C 2011 NIAID 5U19AI066328-07 8033 Hepatitis C Cooperative Research Center Administrative Core ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $81,835
Hepatitis - C 2011 NIAID 272200900055C-4-0-1 B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses DORANZ, BENJAMIN INTEGRAL MOLECULAR PA $1,823,674
Hepatitis - C 2011 NCI 5P20CA150343-03 5626 Hepatitis C and Tumor Suppressors in Hepatocellular LEMON, STANLEY UNIVERSITY OF KENTUCKY KY $276,791
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer